Impact of fingolimod on MRI brain volume measures in RRMS patients with active disease at baseline: results from MS-MRIUS, a longitudinal observational, multicenter real-world outcome study in a clinical routine
Keyword(s):
2017 ◽
Vol 39
(2)
◽
pp. 289-295
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 278
◽
pp. 69-76
◽
2020 ◽
Vol 35
(8)
◽
pp. 1587-1598
Keyword(s):
Keyword(s):
2002 ◽
Vol 8
(2)
◽
pp. 119-123
◽